High Expression of CLEC11A Predicts Favorable Prognosis in Acute Myeloid Leukemia

ConclusionCLEC11A may be used as a prognostic biomarker, and could do benefit for AML patients by providing precise treatment indications, and its unique gene pattern should aid in further understanding the heterogeneous AML mechanisms.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research